Trends on the role of PET in drug development:
Drug development is very expensive and a fight against time. PET offers possibilities to speed up this process by adding unique in vivo information on pharmacokinetics/dynamics of a drug at an early stage. This information can help decision makers to move the drug in the drug development process or...
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
Singapore
World Scientific Pub. Co.
c2012
|
Schlagworte: | |
Online-Zugang: | FHN01 Volltext |
Zusammenfassung: | Drug development is very expensive and a fight against time. PET offers possibilities to speed up this process by adding unique in vivo information on pharmacokinetics/dynamics of a drug at an early stage. This information can help decision makers to move the drug in the drug development process or to decide to stop further developments. This unique and complete book highlights the different ways PET can be used and describes the latest trends in the various disciplines within nuclear medicine to further improve methodologies and increase the number of tools to accelerate drug development. Various topics within tracer development, instrumentation, data analysis and many clinical and preclinical topics are described by leading scientists from the industry and academia |
Beschreibung: | xxx, 768 p. ill. (some col.) |
ISBN: | 9789814317740 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV044638187 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 171120s2012 |||| o||u| ||||||eng d | ||
020 | |a 9789814317740 |c electronic bk. |9 978-981-4317-74-0 | ||
024 | 7 | |a 10.1142/7851 |2 doi | |
035 | |a (ZDB-124-WOP)00002623 | ||
035 | |a (OCoLC)1012706631 | ||
035 | |a (DE-599)BVBBV044638187 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-92 | ||
082 | 0 | |a 616.07575 |2 22 | |
084 | |a YR 2520 |0 (DE-625)154095: |2 rvk | ||
245 | 1 | 0 | |a Trends on the role of PET in drug development |c edited by Philip H. Elsinga ... [et al.] |
264 | 1 | |a Singapore |b World Scientific Pub. Co. |c c2012 | |
300 | |a xxx, 768 p. |b ill. (some col.) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
520 | |a Drug development is very expensive and a fight against time. PET offers possibilities to speed up this process by adding unique in vivo information on pharmacokinetics/dynamics of a drug at an early stage. This information can help decision makers to move the drug in the drug development process or to decide to stop further developments. This unique and complete book highlights the different ways PET can be used and describes the latest trends in the various disciplines within nuclear medicine to further improve methodologies and increase the number of tools to accelerate drug development. Various topics within tracer development, instrumentation, data analysis and many clinical and preclinical topics are described by leading scientists from the industry and academia | ||
650 | 4 | |a Tomography, Emission | |
650 | 4 | |a Nuclear medicine | |
650 | 4 | |a Radiology | |
650 | 4 | |a Diagnostic imaging | |
650 | 0 | 7 | |a Positronen-Emissions-Tomografie |0 (DE-588)4129799-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
655 | 7 | |8 2\p |0 (DE-588)4522595-3 |a Fallstudiensammlung |2 gnd-content | |
689 | 0 | 0 | |a Positronen-Emissions-Tomografie |0 (DE-588)4129799-4 |D s |
689 | 0 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
689 | 0 | |8 3\p |5 DE-604 | |
700 | 1 | |a Elsinga, Philip H. |e Sonstige |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789814317733 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 981431773X |
856 | 4 | 0 | |u http://www.worldscientific.com/worldscibooks/10.1142/7851#t=toc |x Verlag |z URL des Erstveroeffentlichers |3 Volltext |
912 | |a ZDB-124-WOP | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-030036161 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u http://www.worldscientific.com/worldscibooks/10.1142/7851#t=toc |l FHN01 |p ZDB-124-WOP |q FHN_PDA_WOP |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804178054555107328 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV044638187 |
classification_rvk | YR 2520 |
collection | ZDB-124-WOP |
ctrlnum | (ZDB-124-WOP)00002623 (OCoLC)1012706631 (DE-599)BVBBV044638187 |
dewey-full | 616.07575 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.07575 |
dewey-search | 616.07575 |
dewey-sort | 3616.07575 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03000nmm a2200541zc 4500</leader><controlfield tag="001">BV044638187</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">171120s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789814317740</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-981-4317-74-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1142/7851</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-124-WOP)00002623</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1012706631</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044638187</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-92</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.07575</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YR 2520</subfield><subfield code="0">(DE-625)154095:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Trends on the role of PET in drug development</subfield><subfield code="c">edited by Philip H. Elsinga ... [et al.]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Singapore</subfield><subfield code="b">World Scientific Pub. Co.</subfield><subfield code="c">c2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxx, 768 p.</subfield><subfield code="b">ill. (some col.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Drug development is very expensive and a fight against time. PET offers possibilities to speed up this process by adding unique in vivo information on pharmacokinetics/dynamics of a drug at an early stage. This information can help decision makers to move the drug in the drug development process or to decide to stop further developments. This unique and complete book highlights the different ways PET can be used and describes the latest trends in the various disciplines within nuclear medicine to further improve methodologies and increase the number of tools to accelerate drug development. Various topics within tracer development, instrumentation, data analysis and many clinical and preclinical topics are described by leading scientists from the industry and academia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tomography, Emission</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Radiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diagnostic imaging</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Positronen-Emissions-Tomografie</subfield><subfield code="0">(DE-588)4129799-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">2\p</subfield><subfield code="0">(DE-588)4522595-3</subfield><subfield code="a">Fallstudiensammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Positronen-Emissions-Tomografie</subfield><subfield code="0">(DE-588)4129799-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Elsinga, Philip H.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789814317733</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">981431773X</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.worldscientific.com/worldscibooks/10.1142/7851#t=toc</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveroeffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-124-WOP</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030036161</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.worldscientific.com/worldscibooks/10.1142/7851#t=toc</subfield><subfield code="l">FHN01</subfield><subfield code="p">ZDB-124-WOP</subfield><subfield code="q">FHN_PDA_WOP</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content 2\p (DE-588)4522595-3 Fallstudiensammlung gnd-content |
genre_facet | Aufsatzsammlung Fallstudiensammlung |
id | DE-604.BV044638187 |
illustrated | Illustrated |
indexdate | 2024-07-10T07:57:52Z |
institution | BVB |
isbn | 9789814317740 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030036161 |
oclc_num | 1012706631 |
open_access_boolean | |
owner | DE-92 |
owner_facet | DE-92 |
physical | xxx, 768 p. ill. (some col.) |
psigel | ZDB-124-WOP ZDB-124-WOP FHN_PDA_WOP |
publishDate | 2012 |
publishDateSearch | 2012 |
publishDateSort | 2012 |
publisher | World Scientific Pub. Co. |
record_format | marc |
spelling | Trends on the role of PET in drug development edited by Philip H. Elsinga ... [et al.] Singapore World Scientific Pub. Co. c2012 xxx, 768 p. ill. (some col.) txt rdacontent c rdamedia cr rdacarrier Drug development is very expensive and a fight against time. PET offers possibilities to speed up this process by adding unique in vivo information on pharmacokinetics/dynamics of a drug at an early stage. This information can help decision makers to move the drug in the drug development process or to decide to stop further developments. This unique and complete book highlights the different ways PET can be used and describes the latest trends in the various disciplines within nuclear medicine to further improve methodologies and increase the number of tools to accelerate drug development. Various topics within tracer development, instrumentation, data analysis and many clinical and preclinical topics are described by leading scientists from the industry and academia Tomography, Emission Nuclear medicine Radiology Diagnostic imaging Positronen-Emissions-Tomografie (DE-588)4129799-4 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content 2\p (DE-588)4522595-3 Fallstudiensammlung gnd-content Positronen-Emissions-Tomografie (DE-588)4129799-4 s Arzneimittelentwicklung (DE-588)4143176-5 s 3\p DE-604 Elsinga, Philip H. Sonstige oth Erscheint auch als Druck-Ausgabe 9789814317733 Erscheint auch als Druck-Ausgabe 981431773X http://www.worldscientific.com/worldscibooks/10.1142/7851#t=toc Verlag URL des Erstveroeffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Trends on the role of PET in drug development Tomography, Emission Nuclear medicine Radiology Diagnostic imaging Positronen-Emissions-Tomografie (DE-588)4129799-4 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
subject_GND | (DE-588)4129799-4 (DE-588)4143176-5 (DE-588)4143413-4 (DE-588)4522595-3 |
title | Trends on the role of PET in drug development |
title_auth | Trends on the role of PET in drug development |
title_exact_search | Trends on the role of PET in drug development |
title_full | Trends on the role of PET in drug development edited by Philip H. Elsinga ... [et al.] |
title_fullStr | Trends on the role of PET in drug development edited by Philip H. Elsinga ... [et al.] |
title_full_unstemmed | Trends on the role of PET in drug development edited by Philip H. Elsinga ... [et al.] |
title_short | Trends on the role of PET in drug development |
title_sort | trends on the role of pet in drug development |
topic | Tomography, Emission Nuclear medicine Radiology Diagnostic imaging Positronen-Emissions-Tomografie (DE-588)4129799-4 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
topic_facet | Tomography, Emission Nuclear medicine Radiology Diagnostic imaging Positronen-Emissions-Tomografie Arzneimittelentwicklung Aufsatzsammlung Fallstudiensammlung |
url | http://www.worldscientific.com/worldscibooks/10.1142/7851#t=toc |
work_keys_str_mv | AT elsingaphiliph trendsontheroleofpetindrugdevelopment |